NasdaqGM:LFMDHealthcare Services
LifeMD (LFMD) Valuation in Focus After Earnings Miss, Guidance Cut, and WorkSimpli Divestiture
LifeMD (LFMD) turned heads after releasing a mix of disappointing third-quarter earnings and a downward revision to its 2025 revenue and EBITDA forecasts, following its decision to divest its stake in WorkSimpli.
See our latest analysis for LifeMD.
LifeMD’s share price has tumbled in recent weeks, with a 1-day return of -2.44% capping off a much steeper 7-day decline of -21.3% as the market reacted to the lowered 2025 outlook and WorkSimpli divestiture. The one-year total shareholder return...